The Australian, Imaging, Biomarkers and Lifestyle study of ageing (AIBL) Phase III - Facilitating Early Intervention in Preclinical Alzheimer's disease. [ 2014 - 2017 ]

Research Grant

Researchers: Prof Christopher Rowe (Principal investigator) ,  A/Pr Victor Villemagne

Brief description Amyloid brain scans can detect the onset of Alzheimer's disease 10-15 years before symptoms first appear. Amyloid build-up is thought to be the cause of Alzheimer's disease. The earlier that drugs designed to slow the build up of amyloid or to clear it from the brain are given, the greater the chance of benefit. This study will use the recent discoveries from the Australian AIBL study to develop the best method to find these people with brain amyloid but no symptoms for early treatment trials to prevent dementia.

Funding Amount $AUD 733,653.82

Funding Scheme Project Grants

Notes Standard Project Grant